Global Human Injection Flu Vaccine Supply, Demand and Key Producers, 2024-2030

Description

The global Human Injection Flu Vaccine market size is expected to reach $ 11110 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

This report studies the global Human Injection Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Injection Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Injection Flu Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Injection Flu Vaccine total production and demand, 2019-2030, (K Units)
Global Human Injection Flu Vaccine total production value, 2019-2030, (USD Million)
Global Human Injection Flu Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Human Injection Flu Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Human Injection Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Human Injection Flu Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Human Injection Flu Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Human Injection Flu Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Human Injection Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Jiangsu GDK, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Injection Flu Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Human Injection Flu Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Injection Flu Vaccine Market, Segmentation by Type
    Trivalent Influenza Vaccine
    Quadrivalent Influenza Vaccine

Global Human Injection Flu Vaccine Market, Segmentation by Application
    6 Months to 3 Years
    > 3 Years

Companies Profiled:
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    Jiangsu GDK
    KM Biologics

Key Questions Answered
1. How big is the global Human Injection Flu Vaccine market?
2. What is the demand of the global Human Injection Flu Vaccine market?
3. What is the year over year growth of the global Human Injection Flu Vaccine market?
4. What is the production and production value of the global Human Injection Flu Vaccine market?
5. Who are the key producers in the global Human Injection Flu Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Human Injection Flu Vaccine Introduction
    1.2 World Human Injection Flu Vaccine Supply & Forecast
        1.2.1 World Human Injection Flu Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Human Injection Flu Vaccine Production (2019-2030)
        1.2.3 World Human Injection Flu Vaccine Pricing Trends (2019-2030)
    1.3 World Human Injection Flu Vaccine Production by Region (Based on Production Site)
        1.3.1 World Human Injection Flu Vaccine Production Value by Region (2019-2030)
        1.3.2 World Human Injection Flu Vaccine Production by Region (2019-2030)
        1.3.3 World Human Injection Flu Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Human Injection Flu Vaccine Production (2019-2030)
        1.3.5 Europe Human Injection Flu Vaccine Production (2019-2030)
        1.3.6 China Human Injection Flu Vaccine Production (2019-2030)
        1.3.7 Japan Human Injection Flu Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Injection Flu Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Injection Flu Vaccine Major Market Trends

2 Demand Summary
    2.1 World Human Injection Flu Vaccine Demand (2019-2030)
    2.2 World Human Injection Flu Vaccine Consumption by Region
        2.2.1 World Human Injection Flu Vaccine Consumption by Region (2019-2024)
        2.2.2 World Human Injection Flu Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Human Injection Flu Vaccine Consumption (2019-2030)
    2.4 China Human Injection Flu Vaccine Consumption (2019-2030)
    2.5 Europe Human Injection Flu Vaccine Consumption (2019-2030)
    2.6 Japan Human Injection Flu Vaccine Consumption (2019-2030)
    2.7 South Korea Human Injection Flu Vaccine Consumption (2019-2030)
    2.8 ASEAN Human Injection Flu Vaccine Consumption (2019-2030)
    2.9 India Human Injection Flu Vaccine Consumption (2019-2030)

3 World Human Injection Flu Vaccine Manufacturers Competitive Analysis
    3.1 World Human Injection Flu Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Human Injection Flu Vaccine Production by Manufacturer (2019-2024)
    3.3 World Human Injection Flu Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Human Injection Flu Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Human Injection Flu Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Human Injection Flu Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Human Injection Flu Vaccine in 2023
    3.6 Human Injection Flu Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Human Injection Flu Vaccine Market: Region Footprint
        3.6.2 Human Injection Flu Vaccine Market: Company Product Type Footprint
        3.6.3 Human Injection Flu Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Human Injection Flu Vaccine Production Value Comparison
        4.1.1 United States VS China: Human Injection Flu Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Human Injection Flu Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Human Injection Flu Vaccine Production Comparison
        4.2.1 United States VS China: Human Injection Flu Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Human Injection Flu Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Human Injection Flu Vaccine Consumption Comparison
        4.3.1 United States VS China: Human Injection Flu Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Human Injection Flu Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Human Injection Flu Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Human Injection Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Human Injection Flu Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Human Injection Flu Vaccine Production (2019-2024)
    4.5 China Based Human Injection Flu Vaccine Manufacturers and Market Share
        4.5.1 China Based Human Injection Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Human Injection Flu Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Human Injection Flu Vaccine Production (2019-2024)
    4.6 Rest of World Based Human Injection Flu Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Human Injection Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Human Injection Flu Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Human Injection Flu Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Human Injection Flu Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Trivalent Influenza Vaccine
        5.2.2 Quadrivalent Influenza Vaccine
    5.3 Market Segment by Type
        5.3.1 World Human Injection Flu Vaccine Production by Type (2019-2030)
        5.3.2 World Human Injection Flu Vaccine Production Value by Type (2019-2030)
        5.3.3 World Human Injection Flu Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Human Injection Flu Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 6 Months to 3 Years
        6.2.2 > 3 Years
    6.3 Market Segment by Application
        6.3.1 World Human Injection Flu Vaccine Production by Application (2019-2030)
        6.3.2 World Human Injection Flu Vaccine Production Value by Application (2019-2030)
        6.3.3 World Human Injection Flu Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Human Injection Flu Vaccine Product and Services
        7.1.4 Sanofi Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Human Injection Flu Vaccine Product and Services
        7.2.4 CSL Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Human Injection Flu Vaccine Product and Services
        7.3.4 GSK Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Viatris
        7.4.1 Viatris Details
        7.4.2 Viatris Major Business
        7.4.3 Viatris Human Injection Flu Vaccine Product and Services
        7.4.4 Viatris Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Viatris Recent Developments/Updates
        7.4.6 Viatris Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Human Injection Flu Vaccine Product and Services
        7.5.4 AstraZeneca Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 Hualan Bio
        7.6.1 Hualan Bio Details
        7.6.2 Hualan Bio Major Business
        7.6.3 Hualan Bio Human Injection Flu Vaccine Product and Services
        7.6.4 Hualan Bio Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Hualan Bio Recent Developments/Updates
        7.6.6 Hualan Bio Competitive Strengths & Weaknesses
    7.7 Changchun Institute of Biological
        7.7.1 Changchun Institute of Biological Details
        7.7.2 Changchun Institute of Biological Major Business
        7.7.3 Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
        7.7.4 Changchun Institute of Biological Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Changchun Institute of Biological Recent Developments/Updates
        7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
    7.8 Sinovac
        7.8.1 Sinovac Details
        7.8.2 Sinovac Major Business
        7.8.3 Sinovac Human Injection Flu Vaccine Product and Services
        7.8.4 Sinovac Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Sinovac Recent Developments/Updates
        7.8.6 Sinovac Competitive Strengths & Weaknesses
    7.9 Jiangsu GDK
        7.9.1 Jiangsu GDK Details
        7.9.2 Jiangsu GDK Major Business
        7.9.3 Jiangsu GDK Human Injection Flu Vaccine Product and Services
        7.9.4 Jiangsu GDK Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Jiangsu GDK Recent Developments/Updates
        7.9.6 Jiangsu GDK Competitive Strengths & Weaknesses
    7.10 KM Biologics
        7.10.1 KM Biologics Details
        7.10.2 KM Biologics Major Business
        7.10.3 KM Biologics Human Injection Flu Vaccine Product and Services
        7.10.4 KM Biologics Human Injection Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 KM Biologics Recent Developments/Updates
        7.10.6 KM Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Injection Flu Vaccine Industry Chain
    8.2 Human Injection Flu Vaccine Upstream Analysis
        8.2.1 Human Injection Flu Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Human Injection Flu Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Human Injection Flu Vaccine Production Mode
    8.6 Human Injection Flu Vaccine Procurement Model
    8.7 Human Injection Flu Vaccine Industry Sales Model and Sales Channels
        8.7.1 Human Injection Flu Vaccine Sales Model
        8.7.2 Human Injection Flu Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Human Injection Flu Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Human Injection Flu Vaccine Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Human Injection Flu Vaccine Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Human Injection Flu Vaccine Production Value Market Share by Region (2019-2024)
    Table 5. World Human Injection Flu Vaccine Production Value Market Share by Region (2025-2030)
    Table 6. World Human Injection Flu Vaccine Production by Region (2019-2024) & (K Units)
    Table 7. World Human Injection Flu Vaccine Production by Region (2025-2030) & (K Units)
    Table 8. World Human Injection Flu Vaccine Production Market Share by Region (2019-2024)
    Table 9. World Human Injection Flu Vaccine Production Market Share by Region (2025-2030)
    Table 10. World Human Injection Flu Vaccine Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Human Injection Flu Vaccine Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Human Injection Flu Vaccine Major Market Trends
    Table 13. World Human Injection Flu Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Human Injection Flu Vaccine Consumption by Region (2019-2024) & (K Units)
    Table 15. World Human Injection Flu Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Human Injection Flu Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Human Injection Flu Vaccine Producers in 2023
    Table 18. World Human Injection Flu Vaccine Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Human Injection Flu Vaccine Producers in 2023
    Table 20. World Human Injection Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Human Injection Flu Vaccine Company Evaluation Quadrant
    Table 22. World Human Injection Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Human Injection Flu Vaccine Production Site of Key Manufacturer
    Table 24. Human Injection Flu Vaccine Market: Company Product Type Footprint
    Table 25. Human Injection Flu Vaccine Market: Company Product Application Footprint
    Table 26. Human Injection Flu Vaccine Competitive Factors
    Table 27. Human Injection Flu Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Human Injection Flu Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Human Injection Flu Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Human Injection Flu Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Human Injection Flu Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Human Injection Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Human Injection Flu Vaccine Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Human Injection Flu Vaccine Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Human Injection Flu Vaccine Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Human Injection Flu Vaccine Production Market Share (2019-2024)
    Table 37. China Based Human Injection Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Human Injection Flu Vaccine Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Human Injection Flu Vaccine Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Human Injection Flu Vaccine Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Human Injection Flu Vaccine Production Market Share (2019-2024)
    Table 42. Rest of World Based Human Injection Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Human Injection Flu Vaccine Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Human Injection Flu Vaccine Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Human Injection Flu Vaccine Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Human Injection Flu Vaccine Production Market Share (2019-2024)
    Table 47. World Human Injection Flu Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Human Injection Flu Vaccine Production by Type (2019-2024) & (K Units)
    Table 49. World Human Injection Flu Vaccine Production by Type (2025-2030) & (K Units)
    Table 50. World Human Injection Flu Vaccine Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Human Injection Flu Vaccine Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Human Injection Flu Vaccine Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Human Injection Flu Vaccine Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Human Injection Flu Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Human Injection Flu Vaccine Production by Application (2019-2024) & (K Units)
    Table 56. World Human Injection Flu Vaccine Production by Application (2025-2030) & (K Units)
    Table 57. World Human Injection Flu Vaccine Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Human Injection Flu Vaccine Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Human Injection Flu Vaccine Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Human Injection Flu Vaccine Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Human Injection Flu Vaccine Product and Services
    Table 64. Sanofi Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. CSL Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Major Business
    Table 69. CSL Human Injection Flu Vaccine Product and Services
    Table 70. CSL Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. CSL Recent Developments/Updates
    Table 72. CSL Competitive Strengths & Weaknesses
    Table 73. GSK Basic Information, Manufacturing Base and Competitors
    Table 74. GSK Major Business
    Table 75. GSK Human Injection Flu Vaccine Product and Services
    Table 76. GSK Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. GSK Recent Developments/Updates
    Table 78. GSK Competitive Strengths & Weaknesses
    Table 79. Viatris Basic Information, Manufacturing Base and Competitors
    Table 80. Viatris Major Business
    Table 81. Viatris Human Injection Flu Vaccine Product and Services
    Table 82. Viatris Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Viatris Recent Developments/Updates
    Table 84. Viatris Competitive Strengths & Weaknesses
    Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 86. AstraZeneca Major Business
    Table 87. AstraZeneca Human Injection Flu Vaccine Product and Services
    Table 88. AstraZeneca Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. AstraZeneca Recent Developments/Updates
    Table 90. AstraZeneca Competitive Strengths & Weaknesses
    Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 92. Hualan Bio Major Business
    Table 93. Hualan Bio Human Injection Flu Vaccine Product and Services
    Table 94. Hualan Bio Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Hualan Bio Recent Developments/Updates
    Table 96. Hualan Bio Competitive Strengths & Weaknesses
    Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 98. Changchun Institute of Biological Major Business
    Table 99. Changchun Institute of Biological Human Injection Flu Vaccine Product and Services
    Table 100. Changchun Institute of Biological Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Changchun Institute of Biological Recent Developments/Updates
    Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
    Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 104. Sinovac Major Business
    Table 105. Sinovac Human Injection Flu Vaccine Product and Services
    Table 106. Sinovac Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Sinovac Recent Developments/Updates
    Table 108. Sinovac Competitive Strengths & Weaknesses
    Table 109. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 110. Jiangsu GDK Major Business
    Table 111. Jiangsu GDK Human Injection Flu Vaccine Product and Services
    Table 112. Jiangsu GDK Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Jiangsu GDK Recent Developments/Updates
    Table 114. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 115. KM Biologics Major Business
    Table 116. KM Biologics Human Injection Flu Vaccine Product and Services
    Table 117. KM Biologics Human Injection Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 118. Global Key Players of Human Injection Flu Vaccine Upstream (Raw Materials)
    Table 119. Human Injection Flu Vaccine Typical Customers
    Table 120. Human Injection Flu Vaccine Typical Distributors
List of Figure
    Figure 1. Human Injection Flu Vaccine Picture
    Figure 2. World Human Injection Flu Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Human Injection Flu Vaccine Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Human Injection Flu Vaccine Production (2019-2030) & (K Units)
    Figure 5. World Human Injection Flu Vaccine Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Human Injection Flu Vaccine Production Value Market Share by Region (2019-2030)
    Figure 7. World Human Injection Flu Vaccine Production Market Share by Region (2019-2030)
    Figure 8. North America Human Injection Flu Vaccine Production (2019-2030) & (K Units)
    Figure 9. Europe Human Injection Flu Vaccine Production (2019-2030) & (K Units)
    Figure 10. China Human Injection Flu Vaccine Production (2019-2030) & (K Units)
    Figure 11. Japan Human Injection Flu Vaccine Production (2019-2030) & (K Units)
    Figure 12. Human Injection Flu Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 15. World Human Injection Flu Vaccine Consumption Market Share by Region (2019-2030)
    Figure 16. United States Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 17. China Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 18. Europe Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 19. Japan Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 22. India Human Injection Flu Vaccine Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Human Injection Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Injection Flu Vaccine Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Injection Flu Vaccine Markets in 2023
    Figure 26. United States VS China: Human Injection Flu Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Human Injection Flu Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Human Injection Flu Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Human Injection Flu Vaccine Production Market Share 2023
    Figure 30. China Based Manufacturers Human Injection Flu Vaccine Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Human Injection Flu Vaccine Production Market Share 2023
    Figure 32. World Human Injection Flu Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Human Injection Flu Vaccine Production Value Market Share by Type in 2023
    Figure 34. Trivalent Influenza Vaccine
    Figure 35. Quadrivalent Influenza Vaccine
    Figure 36. World Human Injection Flu Vaccine Production Market Share by Type (2019-2030)
    Figure 37. World Human Injection Flu Vaccine Production Value Market Share by Type (2019-2030)
    Figure 38. World Human Injection Flu Vaccine Average Price by Type (2019-2030) & (US$/Unit)
    Figure 39. World Human Injection Flu Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Human Injection Flu Vaccine Production Value Market Share by Application in 2023
    Figure 41. 6 Months to 3 Years
    Figure 42. > 3 Years
    Figure 43. World Human Injection Flu Vaccine Production Market Share by Application (2019-2030)
    Figure 44. World Human Injection Flu Vaccine Production Value Market Share by Application (2019-2030)
    Figure 45. World Human Injection Flu Vaccine Average Price by Application (2019-2030) & (US$/Unit)
    Figure 46. Human Injection Flu Vaccine Industry Chain
    Figure 47. Human Injection Flu Vaccine Procurement Model
    Figure 48. Human Injection Flu Vaccine Sales Model
    Figure 49. Human Injection Flu Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Companies Mentioned

Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics